Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Personal journeys to and in human genetics and dysmorphology.

Schwartz CE. et al, (2024), Am J Med Genet A, 194

Therapeutic approaches for Duchenne muscular dystrophy.

Roberts TC. et al, (2023), Nat Rev Drug Discov, 22, 917 - 934

Utrophin correlates with disease severity in Duchenne muscular dystrophy.

Guiraud S. and Davies K., (2023), Med, 4, 220 - 222

Highway to HHGE: An Interview with Dame Kay E. Davies.

Davies K. and Davies KE., (2020), CRISPR J, 3, 325 - 331

From diagnosis to therapy in Duchenne muscular dystrophy.

Babbs A. et al, (2020), Biochem Soc Trans

The Long Journey from Diagnosis to Therapy.

Davies KE., (2020), Annu Rev Genomics Hum Genet

Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.

Tambuyzer E. et al, (2019), Nature reviews. Drug discovery

Surrogate gene therapy for muscular dystrophy

Davies KE. and Chamberlain JS., (2019), Nature Medicine, 25, 1473 - 1474

Regenerative biomarkers for Duchenne muscular dystrophy

Guiraud S. and Davies KE., (2019), Neural Regeneration Research, 14, 1317 - 1320

Micro-dystrophin Genes Bring Hope of an Effective Therapy for Duchenne Muscular Dystrophy

Davies KE. and Guiraud S., (2019), Molecular therapy : the journal of the American Society of Gene Therapy, 27, 486 - 488

Load More